ACT Capital Management »

Alpha Cognition shares owned by ACT Capital Management

Quarter-by-quarter ownership of Alpha Cognition (ACOG) shares owned by ACT Capital Management from 13F filings

Historical chart of ACT Capital Management investment in Alpha Cognition

Tip: Access up to 7 years of quarterly data

All positions including Alpha Cognition held by ACT Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alpha Cognition by ACT Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $335k 52k 6.50

More positions owned by ACT Capital Management

Krystal Biotech (KRYS)
Chevron Corporation (CVX)
Exxon Mobil Corporation (XOM)
Abivax Sponsored Ads (ABVX)
Tg Therapeutics (TGTX)
Viking Therapeutics (VKTX)
Celcuity (CELC)
Amazon (AMZN)
Nuvation Bio Com Cl A (NUVB)
Arrowhead Pharmaceuticals (ARWR)
Cytokinetics (CYTK)
Celcuity Inc Com Mar 20 26 $50 Call Option
Structure Therapeutics Sponsored Ads (GPCR)
Grayscale Bitcoin Trust Etf Shs Rep Com Ut (GBTC)
Figure Technology Solutions Com Cl A (FIGR)

View all positions for ACT Capital Management

Top funds holding Alpha Cognition

Opaleye Management
Solas Capital Management
AWM Investment Company
Cable Car Capital
Ikarian Capital
Sphera Funds Management
Alyeska Investment Group
Boothbay Fund Management
Aristides Capital
Cantor Fitzgerald, L. P.
Corsair Capital Management
St. Denis J. Villere & Co
Tudor Investment Corporation
Marshall Wace
ACT Capital Management

View all funds holding Alpha Cognition